2011 Session Powerpoints
All presentations are Microsoft PowerPoint Shows, click on each title to download
Friday, April 29, 2011
SESSION I – GUEST SPEAKER PRESENTATIONS
Moderator: Martin R. Back, MD
Economics of Treating Carotid and AAA Disease - How Treatment Modality Affects Hospital Bottom Line by W. Charles Sternbergh, III, MD
The Evolving Roles of CAS and CEA for Carotid Occlusive Disease by William D. Jordan, MD
Managing Acute and Chronic Aortic Dissection by Rodney A. White, MD
SESSION II - FLORIDA VASCULAR FOUNDATION: RESIDENT, FELLOW & MEDICAL STUDENT ABSTRACT PRESENTATIONS
Moderator: Peter R. Nelson, MD
A Case Report of Complex Endovascular Arch Debranching and TEVAR for Repair of an Aortic Arch Aneurysm by Brett A. Almond, MD, PhD (University of Florida, Gainesville, FL)
Outcome of Combined Carotid-Great Vessel Intervention for Complex Extracranial Atherosclerotic Disease by Kelley Hodgkiss-Harlow, MD (University of South Florida, Tampa, FL)
Endovascular Aorto-Bi-Iliac Repair of Aorta-Bi-Iliac Occlusive Disease: Expanding the Use of Current Endovascular Aortic Unibody Stents by Robert M. Van Haren, MD (University of Miami, Miami, FL)
The State of Endovenous Ablation for Venous Insufficiency in Florida by Michael Hong, MD (University of Florida, Gainesville, FL)
Origin of Neointimal Cells in Arteriovenous Fistula: Bone Marrow, Artery or the Vein Itself? by Eddie W. Manning, MD (University of Miami, Miami, FL)
Patient Demographics as Indicators of Endovascular Versus Open Revascularization in Chronic Mesenteric Ischemia in Florida by Khayree Butler, MD (University of Florida, Gainesville, FL)
Predictors of Mortality with Blunt Thoracic Aortic Injury by Kyle Vincent, MD (Orlando Regional Health Care Center, Orlando, FL)
A 10-Year Appraisal of Carotid Endarterectomy – Stroke-Free Survival and Recurrence of Disease by Thomas C. Matthews, MD (University of Alabama, Birmingham, AL)
Patch Versus Non-Patch Primary Closure – Restenosis Rate is Equivalent by Max Citrin, Medical Student (Nova Southeastern University, Ft. Lauderdale, FL)
Saturday, April 30, 2011
SESSION III – ABSTRACT PRESENTATIONS
Managing Complex Aortic Necks During EVAR by Manish Mehta, MD
Large Balloon Expandable Stents to Treat Intra- Operative Type I Endoleaks in Patients with Hostile Necks by Karthikeshwar Kasirajan, MD
Early Experience with the Use of a Novel Endovascular Device to Cross Chronic Total Occlusions of the Superficial Femoral and Popliteal Arterial Segments by Chris J. LeCroy, MD
Real-World Results CONFIRM Application of Orbital Treatment in Effectively Modifying Noncompliant Lesion Morphology and Successfully Restoring Ample Blood Flow in Patients with Calcific Peripheral Arterial Disease by Russell Lam, MD
The Endurant Stent Graft System: Results of the Regulatory Pivotal Study by Russell H. Samson, MD
SESSION IV – AAA SYMPOSIUM
Moderator: Martin R. Back, MD
EVAR Panel
Rodney White, MD; W. Charles Sternbergh, III, MD; William Jordan, MD
Treating the Disadvantaged Infrarenal Neck (Short, Angled, Wide, Conical)
Rodney White, MD; W. Charles Sternbergh, III, MD; William Jordan, MD
Long-Term Device Stability and AAA Exclusion (Beyond 3-5 Years)
Rodney White, MD; W. Charles Sternbergh, III, MD; William Jordan, MD
Sunday, May 1, 2011
SESSION V – ABSTRACT PRESENTATIONS
Florida Vascular Study Group by Adam Beck, MD
Developments in Vascular Imaging - What Vascular Surgeons Should Know by Rodney A. White, MD
New Advances for CTO Recanalization by Thomas A. Abbruzzese, MD
Laser Ablation of Saphenous Veins is Negatively Affected by Alteration of the Fiber Tip to Prevent Inadvertent Contact with the Vein Wall by Russell H. Samson, MD
Iliocaval Venous Outflow Disease: IVUS/Stenting by Jose I. Almeida, MD
SESSION VI – ABSTRACT & CASE PRESENTATIONS
Midterm Results of The Propaten® Heparin-Bonded EPTFE Graft by Russell H. Samson, MD
Optimizing a Surveillance Regimen After EVAR by W. Charles Sternbergh, III, MD
MEMBER CASE PRESENTATION
Exsanguinating Hemorrhage in a Patient Following EVAR, Right Iliac Stent Insertion, on Direct Thrombin Inhibitors by Arthur E. Palamara, MD
This activity has been approved for AMA PRA Category 1 Credit™
